Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Novartis (Australia) | Researchclopedia

Back to institutions

Novartis (Australia)

Preston, Victoriacompany

192

Works

16,502

Citations

50

h-index

Top Research Topics

Chronic Myeloid Leukemia Treatments Chronic Lymphocytic Leukemia Research Eosinophilic Disorders and Syndromes

Top Researchers

Paul Glasziou Bond University

1,172 works119,455 citationsh-index: 145

Recent Research

3563 Real-world use of ofatumumab in relapsing MS: interim analysis of patient-reported and clinical outcomes from EAFToS part II

Anneke van der Walt,Simon Broadley,et al.

20250 citations

Helminth infection and control

Blood Pressure and Hypertension Studies

Health Systems, Economic Evaluations, Quality of Life

Acute Lymphoblastic Leukemia research

Multiple Sclerosis Research Studies

Lymphoma Diagnosis and Treatment

Parasite Biology and Host Interactions

Coccidia and coccidiosis research

Bone health and treatments

Peter R. Schofield

806 works66,551 citationsh-index: 116

Timothy P. Hughes South Australia Pathology

797 works55,547 citationsh-index: 94

Ricky W. Johnstone Peter MacCallum Cancer Centre

780 works37,889 citationsh-index: 96

Les Irwig The University of Sydney

435 works37,349 citationsh-index: 78

Andrew Spencer The Alfred Hospital

839 works34,381 citationsh-index: 80

3557 Characterizing ofatumumab patient onboarding and utilization in relapsing multiple sclerosis using MSGo: 3rd interim analysis EAFToS part I

Todd A. Hardy,Anneke van der Walt,et al.

20250 citations

Lp(a) Testing and LDL-C Levels Among Australian ASCVD Patients in 2022: A Cross-Sectional Study From the Advara Heartcare Network (PREVAIL)

D. Eccleston,R. Deans,et al.

20250 citations

LDL-C Target Attainment and Statin Use in Patients With ASCVD, Familial Hypercholesterolaemia, and Those Otherwise at Moderate/High-Risk of ASCVD in Australian General Practice (SCOPE-GP)

Gerald F. Watts,Ralph Audehm,et al.

20250 citations

Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in Australian Hospitals

Ian Woodcock,Didu Kariyawasam,et al.

20252 citations

156. Safety of Remibrutinib across Immune-mediated Diseases Supports Development in Multiple Sclerosis

Bernd C. Kieseier,Xavier Montalbán,et al.

20240 citations